120 related articles for article (PubMed ID: 36711882)
1. Development and characterization of new patient-derived xenograft (PDX) models of osteosarcoma with distinct metastatic capacities.
Schott CR; Koehne AL; Sayles LC; Young EP; Luck C; Yu K; Lee AG; Breese MR; Leung SG; Xu H; Shah AT; Liu HY; Spillinger A; Behroozfard IH; Marini KD; Dinh PT; Pons Ventura MAV; Vanderboon EN; Hazard FK; Cho SJ; Avedian RS; Mohler DG; Zimel M; Wustrack R; Curtis C; Sirota M; Sweet-Cordero EA
bioRxiv; 2023 Jan; ():. PubMed ID: 36711882
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
Schott CR; Koehne AL; Sayles LC; Young EP; Luck C; Yu K; Lee AG; Breese MR; Leung SG; Xu H; Shah AT; Liu HY; Spillinger A; Behroozfard IH; Marini KD; Dinh PT; Pons Ventura MV; Vanderboon EN; Hazard FK; Cho SJ; Avedian RS; Mohler DG; Zimel M; Wustrack R; Curtis C; Sirota M; Sweet-Cordero EA
Clin Cancer Res; 2024 Feb; 30(4):849-864. PubMed ID: 37703185
[TBL] [Abstract][Full Text] [Related]
3. Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma.
Landuzzi L; Manara MC; Lollini PL; Scotlandi K
Cells; 2021 Feb; 10(2):. PubMed ID: 33671173
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.
Braekeveldt N; Wigerup C; Gisselsson D; Mohlin S; Merselius M; Beckman S; Jonson T; Börjesson A; Backman T; Tadeo I; Berbegall AP; Ora I; Navarro S; Noguera R; Påhlman S; Bexell D
Int J Cancer; 2015 Mar; 136(5):E252-61. PubMed ID: 25220031
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived xenografts as preclinical neuroblastoma models.
Braekeveldt N; Bexell D
Cell Tissue Res; 2018 May; 372(2):233-243. PubMed ID: 28924803
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models.
da Costa MEM; Droit R; Khneisser P; Gomez-Brouchet A; Adam-de-Beaumais T; Nolla M; Signolles N; Torrejon J; Lombard B; Loew D; Ayrault O; Scoazec JY; Geoerger B; Vassal G; Marchais A; Gaspar N
Front Oncol; 2023; 13():1166063. PubMed ID: 37377921
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of patient-derived xenografts from patients with osteosarcoma.
Chen F; Zhang Z; Shen R; Chen M; Li G; Zhu X
Tissue Cell; 2022 Dec; 79():101911. PubMed ID: 36156374
[TBL] [Abstract][Full Text] [Related]
8. Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
Contreras-Zárate MJ; Ormond DR; Gillen AE; Hanna C; Day NL; Serkova NJ; Jacobsen BM; Edgerton SM; Thor AD; Borges VF; Lillehei KO; Graner MW; Kabos P; Cittelly DM
Front Oncol; 2017; 7():252. PubMed ID: 29164052
[TBL] [Abstract][Full Text] [Related]
9. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.
Peng S; Creighton CJ; Zhang Y; Sen B; Mazumdar T; Myers JN; Lai SY; Woolfson A; Lorenzi MV; Bell D; Williams MD; Johnson FM
J Transl Med; 2013 Aug; 11():198. PubMed ID: 23981300
[TBL] [Abstract][Full Text] [Related]
10. The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Palanisamy N; Yang J; Shepherd PDA; Li-Ning-Tapia EM; Labanca E; Manyam GC; Ravoori MK; Kundra V; Araujo JC; Efstathiou E; Pisters LL; Wan X; Wang X; Vazquez ES; Aparicio AM; Carskadon SL; Tomlins SA; Kunju LP; Chinnaiyan AM; Broom BM; Logothetis CJ; Troncoso P; Navone NM
Clin Cancer Res; 2020 Sep; 26(18):4933-4946. PubMed ID: 32576626
[TBL] [Abstract][Full Text] [Related]
11. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.
Maniakas A; Henderson YC; Hei H; Peng S; Chen Y; Jiang Y; Ji S; Cardenas M; Chiu Y; Bell D; Williams MD; Hofmann MC; Scherer SE; Wheeler DA; Busaidy NL; Dadu R; Wang JR; Cabanillas ME; Zafereo M; Johnson FM; Lai SY
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4652-e4665. PubMed ID: 34147031
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma.
Song S; Xu Y; Huo L; Zhao S; Wang R; Li Y; Scott AW; Pizzi MP; Wang Y; Fan Y; Harada K; Jin J; Ma L; Yao X; Shanbhag ND; Gan Q; Roy-Chowdhuri S; Badgwell BD; Wang Z; Wang L; Ajani JA
J Exp Clin Cancer Res; 2021 Jun; 40(1):207. PubMed ID: 34162421
[TBL] [Abstract][Full Text] [Related]
13. Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma.
Vaubel RA; Tian S; Remonde D; Schroeder MA; Mladek AC; Kitange GJ; Caron A; Kollmeyer TM; Grove R; Peng S; Carlson BL; Ma DJ; Sarkar G; Evers L; Decker PA; Yan H; Dhruv HD; Berens ME; Wang Q; Marin BM; Klee EW; Califano A; LaChance DH; Eckel-Passow JE; Verhaak RG; Sulman EP; Burns TC; Meyer FB; O'Neill BP; Tran NL; Giannini C; Jenkins RB; Parney IF; Sarkaria JN
Clin Cancer Res; 2020 Mar; 26(5):1094-1104. PubMed ID: 31852831
[TBL] [Abstract][Full Text] [Related]
14. Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib.
Lee AQ; Ijiri M; Rodriguez R; Gandour-Edwards R; Lee J; Tepper CG; Li Y; Beckett L; Lam K; Goodwin N; Satake N
Front Oncol; 2021; 11():648097. PubMed ID: 33842362
[TBL] [Abstract][Full Text] [Related]
15. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
[TBL] [Abstract][Full Text] [Related]
16. Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.
Lang H; Béraud C; Cabel L; Fontugne J; Lassalle M; Krucker C; Dufour F; Groeneveld CS; Dixon V; Meng X; Kamoun A; Chapeaublanc E; De Reynies A; Gamé X; Rischmann P; Bieche I; Masliah-Planchon J; Beaurepere R; Allory Y; Lindner V; Misseri Y; Radvanyi F; Lluel P; Bernard-Pierrot I; Massfelder T
Front Oncol; 2022; 12():930731. PubMed ID: 36033544
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
[TBL] [Abstract][Full Text] [Related]
18. An association between successful engraftment of osteosarcoma patient-derived xenografts and clinicopathological findings.
Fortuna-Costa A; Granato RA; Meohas W; Lopes ACS; Caruso AC; Castro E Silva Pinheiro R; d'Eça PDG; Dias RB; Perini JA; Barbosa APF; Moreira de Sá RA; Guimarães JAM; Murray SS; Duarte MEL
Histol Histopathol; 2020 Nov; 35(11):1295-1307. PubMed ID: 32964941
[TBL] [Abstract][Full Text] [Related]
19. Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior.
Scott MC; Tomiyasu H; Garbe JR; Cornax I; Amaya C; O'Sullivan MG; Subramanian S; Bryan BA; Modiano JF
Dis Model Mech; 2016 Dec; 9(12):1435-1444. PubMed ID: 27874835
[TBL] [Abstract][Full Text] [Related]
20. Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
Jakša R; Karolová J; Svatoň M; Kazantsev D; Grajciarová M; Pokorná E; Tonar Z; Klánová M; Winkowska L; Maláriková D; Vočková P; Forsterová K; Renešová N; Dolníková A; Nožičková K; Dundr P; Froňková E; Trněný M; Klener P
Lab Invest; 2022 Sep; 102(9):957-965. PubMed ID: 35488033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
